drugset

drugset / Trial / NCT00294320

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

NCT00294320 ↗

Phase 3 Completed 12 enrolled MEDA Pharma GmbH & Co. KG

RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to evaluate the performance of two techniques to monitor the clearance of AK lesions when treated with Aldara 5% cream.

Timeline

Start: 2006-02
Primary completion: 2007-01
Completion: 2007-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Imiquimod	Other / unclassified	250 mg	—

Indications